Of greater concern are potential risks from combination use: Hypoglycaemia risk: Retatrutide enhances insulin secretion in a glucose-dependent manner, which carries a low intrinsic hypoglycaemia risk when used alone
Kristi Perry, PA-C Eli Luft, PA-C Key Takeaways 1
It belongs to a group of compounds known as growth hormone secretagogues, which means they encourage the body to release growth hormone naturally
The main practical risks are: Injection-site soreness, bruising or mild redness , which settles within a day or two
These injections can help regulate insulin and glucose metabolism, which is essential for maintaining a healthy weight [5]
Although after 4 to 6 injections if they do not feel any benefits then there is a possibility that the B12 is more than likely not going to be effective